Rome Therapeutics has a total of 8 patents globally. Of these 8 patents, all the patents are active. The United States of America is where Rome Therapeutics has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin
Qpex Biopharma has a total of 95 patents globally, out of which 34 have been granted. Of these 95 patents, more than 93% patents are active. The United States of America is where Qpex Biopharma has filed the maximum number of patents, followed by Europe. Parallelly, United States of America
Eternatear has a total of 15 patents globally, out of which 3 have been granted. Of these 15 patents, more than 86% patents are active. The United States of America is where Eternatear has filed the maximum number of patents. Parallelly, United States of America seems to be the main
CoImmune has a total of 142 patents globally, out of which 92 have been granted. Of these 142 patents, more than 76% patents are active. The United States of America is where CoImmune has filed the maximum number of patents, followed by Australia. Parallelly, United States of America seems to
Zelp has a total of 41 patents globally, out of which 13 have been granted. Of these 41 patents, more than 87% patents are active. The United Kingdom is where Zelp has filed the maximum number of patents. Parallelly, UK seems to be the main focused R&D center of Zelp
128 Technology has a total of 121 patents globally, out of which 55 have been granted. Of these 121 patents, more than 63% patents are active. The USA is where 128 Technology has filed the maximum number of patents, followed by Europe (EPO). Parallelly, the United States seems to be
Bigfoot Biomedical has a total of 435 patents globally, out of which 182 have been granted. Of these 435 patents, more than 74% patents are active. The USA is where Bigfoot Biomedical has filed the maximum number of patents, followed by Europe (EPO) and Hong Kong. Parallelly, the United States
Dispersive Networks has a total of 61 patents globally, out of which 48 have been granted. Of these 61 patents, more than 80% patents are active. The USA is where Dispersive Networks has filed the maximum number of patents. Parallelly, the USA seems to be the main focused R&D center
Umnai has a total of 59 patents globally, out of which 14 have been granted. Of these 59 patents, more than 72% patents are active. The United States of America is where Umnai has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America
Canopy Biosciences has a total of 24 patents globally, out of which 9 have been granted. Of these 24 patents, more than 87% patents are active. Europe (EPO) is where Canopy Biosciences has filed the maximum number of patents, followed by United States of America. Parallelly, Italy & Austria seems
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.